Walmart announced a partnership with Eli Lilly to make Zepbound, an obesity treatment, available for pickup at its pharmacies nationwide through LillyDirect’s direct-to-consumer platform by mid-November.
Key Takeaways
-
Expanded access: Walmart’s collaboration with Eli Lilly increases the availability of Zepbound vials nationwide, offering patients more convenient ways to obtain the medication.
-
Affordable pricing: Through LillyDirect, Zepbound’s self-pay cost starts at $349 per month—at least 50% lower than many comparable GLP-1 drugs.
-
Retail health milestone: This marks the first retail partnership for LillyDirect, highlighting Walmart’s growing role in advancing consumer health access through pharmacy innovation.
8th & Walton is based in Bentonville: Walmart is our neighbor! Contact us today to set up a free consultation and see what a hometown advantage can do for your company.
